An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient

A novel Coronavirus strain, named "Severe Acute Respiratory Syndrome Coronavirus 2" (SARS-CoV-2) was recently identified as the etiological agent of the COronaVIrus Disease 2019 (COVID-19). Interestingly, a consistent number of COVID-19-associated skin manifestations seem to share a certain degree of vascular damage as common pathogenetic mechanism1 . Vascular injury may be due to the direct damage of endothelial cells by the virus or may represents an epiphenomenon of a dysregulated host inflammatory responses triggered by the infection2 . Here, we describe an unprecedented case of leukocytoclastic vasculitis presenting with a hemorrhagic bullous eruption in a patient affected by COVID-19.